Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW

Impact of intravitreal aflibercept dosing regimens in treatment-naïve patients with neovascular age-related macular degeneration: 2-year results of RAINBOW

Abstract Background To review treatment outcomes from real-world data of patients with neovascular age-related macular degeneration (nAMD) treated with intravitreal aflibercept (IVT-AFL) injection. Methods RAINBOW ( ClinicalTrials.gov , NCT02279537 ) is an ongoing, observational, 4-year study to mon...

Full description

Bibliographic Details
Main Authors: Michel Weber, Marcel Dominguez, Florence Coscas, Céline Faure, Stéphanie Baillif, Laurent Kodjikian, Salomon-Yves Cohen
Format: Article
Language:English
Published: BMC 2020-05-01
Series:BMC Ophthalmology
Subjects:
Intravitreal aflibercept
Neovascular age-related macular degeneration
France
Real-world
Observational
Online Access:http://link.springer.com/article/10.1186/s12886-020-01468-z

Internet

http://link.springer.com/article/10.1186/s12886-020-01468-z

Similar Items